Low to moderate levels of ROS reinforce HO-1’s protective role by promoting anti-apoptotic pathways, thereby facilitating PC progression and enhancing cancer cell survival, treatment resistance, and metastasis [159]. The gene discussed is HMOX1; the disease is pachyonychia congenita.